| Literature DB >> 35270802 |
Susan Magasi1,2, Hilary K Marshall1, Cassandra Winters2, David Victorson3.
Abstract
Eliminating cancer-related disparities is a global public health priority. Approximately 40% of cancer survivors experience long-term effects of cancer which can lead to activity limitations and participation restrictions; yet discussions of disability are largely absent from clinical and research cancer health equity agendas. The purpose of this study was to explore how cancer survivors experience and make sense of the long-term disabling effects of cancer and its treatments. In this qualitative study, data were collected via in-depth semi-structured interviews with survivors of breast cancer, head and neck cancer, and sarcoma (n = 30). Data were analyzed thematically using a 2-phase iterative process proceeding from descriptive to conceptual coding. Survivors experienced a wide range of long-term physical, sensory, cognitive, and emotional effects, that intertwined to restrict their participation in self-care, work, leisure, and social roles. While the interaction between impairments and participation restrictions meets the definition of disability; participants articulated a range of responses when asked about their disability identity, including (1) rejecting, (2) othering, (3) acknowledging, and (4) affirming. Findings may be indicative of structural and internalized ableism which can impede cancer care and survivorship. To support cancer survivors' transition to post-treatment life, cancer care providers should implement anti-ableist practices and engage in frank discussions about cancer's long-term impacts.Entities:
Keywords: ableism; cancer equity; cancer survivorship; identity; persons with disabilities; qualitative methods; stigma
Mesh:
Year: 2022 PMID: 35270802 PMCID: PMC8910238 DOI: 10.3390/ijerph19053112
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
List of Participants (n = 30).
| Survivor | Cancer Type | Age (years) | Gender | Race | Last Cancer Treatment (year) |
|---|---|---|---|---|---|
| Survivor 1 | Sarcoma; Breast | 66 | Female | White | 2019 |
| Survivor 2 | Head and Neck | 47 | Male | White | 2011 |
| Survivor 3 | Breast | 53 | Female | White | 2014 |
| Survivor 4 | Head and Neck | 38 | Male | Unknown | 2016 |
| Survivor 5 | Breast | 53 | Female | White | 2021 |
| Survivor 6 | Head and Neck | 70 | Male | White | 2012 |
| Survivor 7 | Breast | 66 | Female | White | 2014 |
| Survivor 8 | Breast | 58 | Female | White | 2016 |
| Survivor 9 | Head and Neck | 61 | Female | White | 2017 |
| Survivor 10 | Breast | 69 | Female | White | 2010 |
| Survivor 11 | Breast | 69 | Female | White | 2010 |
| Survivor 12 | Head and Neck | 72 | Male | White | 2013 |
| Survivor 13 | Breast | 42 | Female | White | 2016 |
| Survivor 14 | Sarcoma | 67 | Female | White | 2008 |
| Survivor 15 | Breast | 66 | Female | Multiracial | 2020 |
| Survivor 16 | Sarcoma | 22 | Female | White | 2020 |
| Survivor 17 | Breast | 66 | Female | White | 2005 |
| Survivor 18 | Sarcoma | 29 | Female | White | 2021 |
| Survivor 19 | Breast; Lung | 69 | Female | White | 2003 |
| Survivor 20 | Breast | 58 | Female | White | 2019 |
| Survivor 21 | Sarcoma; Breast | 29 | Female | Black | 2019 |
| Survivor 22 | Breast | 63 | Female | White | 2016 |
| Survivor 23 | Breast | 62 | Female | White | 2015 |
| Survivor 24 | Breast | 53 | Female | White | 2008 |
| Survivor 25 | Breast | 48 | Female | White | 2015 |
| Survivor 26 | Head and Neck | 59 | Female | White | 2016 |
| Survivor 27 | Breast | 79 | Female | White | 2016 |
| Survivor 28 | Breast | 69 | Female | White | 2011 |
| Survivor 29 | Breast | 79 | Female | White | 2006 |
| Survivor 30 | Breast | 59 | Female | White | 2006 |
Participant-identified long-term effects with representative quotations.
| Body & Physical Changes | Representative Quotations |
|---|---|
|
Decreased balance Decreased mobility Decreased endurance Decreased range of motion Dysphagia Dysarthria Limb loss Lymphedema Neuropathy Sensory loss—taste, smell Sleep Disturbances Vertigo |
|
|
| |
|
| |
| Brain and Cognitive Changes | |
|
Attention ‘Chemo Brain’ Memory changes Mental exhaustion Mental fuzziness Problem Solving Word Finding |
|
|
| |
| Thoughts and Feelings | |
|
Anxiety Body image Depression Existential crisis Post-traumatic stress |
|
|
| |